# Simultaneous Measurement of EpicArdial and Microvascular ResisTance Via Angiographic FLOW Study

> **NCT07676097** · — · NOT_YET_RECRUITING · sponsor: **AngioInsight** · enrollment: 620 (estimated)

## Conditions studied

- Non-obstructive Coronary Disease
- Acute or Chronic Coronary Artery Disease

## Interventions

- **PROCEDURE:** Patients with intermediate coronary artery stenosis with clinically indicated FFR assessment.
- **PROCEDURE:** Microvascular assessment

## Key facts

- **NCT ID:** NCT07676097
- **Lead sponsor:** AngioInsight
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06
- **Primary completion:** 2027-12
- **Final completion:** 2027-12
- **Target enrollment:** 620 (ESTIMATED)
- **Last updated:** 2026-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07676097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07676097, "Simultaneous Measurement of EpicArdial and Microvascular ResisTance Via Angiographic FLOW Study". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07676097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*